NASDAQ : PEPG
PepGen Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 2.41 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 166.92M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 163.45M |
| Enterprise Value | 62.31M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 69.26M |
| Shares Outstanding | 69.26M |
| Shares Change (YoY) | +85.07% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 0.21% |
| Owned by Institutions (%) | 35.98% |
| Float | 36.14M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.37 |
| P/TBV Ratio | 1.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 13.36 |
| Quick Ratio | 13.02 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -75.45% |
| Return on Assets (ROA) | -39.12% |
| Return on Invested Capital (ROIC) | -42.42% |
| Return on Capital Employed (ROCE) | -57.59% |
| Weighted Average Cost of Capital (WACC) | 13.96% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.26M |
| Employee Count | 57 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 80,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.02 |
| 52-Week Price Change | -47.67% |
| 50-Day Moving Average | 2.75 |
| 200-Day Moving Average | 3.03 |
| Relative Strength Index (RSI) | 42.01 |
| Average Volume (20 Days) | 992,132 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.80M |
| Short Previous Month | 4.23M |
| Short % of Shares Out | 5.49% |
| Short % of Float | 10.53% |
| Short Ratio (days to cover) | 4.72 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -76.24M |
| Pretax Income | -71.86M |
| Net Income | -71.94M |
| EBITDA | -74.99M |
| EBIT | -76.24M |
| Earnings Per Share (EPS) | -$1.19 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 117.24M |
| Total Debt | 16.09M |
| Net Cash | 101.15M |
| Net Cash Per Share | $1.46 |
| Equity (Book Value) | 119.53M |
| Book Value Per Share | 1.73 |
| Working Capital | 111.32M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -69.34M |
| Capital Expenditures | -126,000 |
| Depreciation & Amortization | 1.25M |
| Net Borrowing | n/a |
| Free Cash Flow | -69.46M |
| FCF Per Share | -$1.00 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -85.07% |
| Shareholder Yield | n/a |
| Earnings Yield | -50.44% |
| FCF Yield | -42.50% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $10.19 |
| Price Target Difference | 331.78% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |